Susan C. Adeniyi-Jones, MD

�ֲ��ý Children's Health, Philadelphia 833 Chestnut St. E. Suite 300 - Specialty Care Philadelphia, PA 19107

Buprenorphine vs. morphine: impact on neonatal opioid withdrawal syndrome (NOWS) outcomes in a single center retrospective study; Journal of Perinatology; (2025).
Abstinence scoring algorithms for treatment of neonatal opioid withdrawal syndrome (NOWS); Journal of Perinatology; (2024).
Algorithms for treatment of Neonatal Opioid Withdrawal Syndrome (NOWS) based on Modified and Abbreviated Finnegan Symptom Score; Unknown Source; (2023).
Ondansetron to reduce neonatal opioid withdrawal severity a randomized clinical trial; Journal of Perinatology; (2023).
Polygenic risk scores and the need for pharmacotherapy in neonatal abstinence syndrome.; Pediatric research; (2022).
Pharmacometric dose optimization of buprenorphine in neonatal opioid withdrawal syndrome; Clinical and Translational Science; (2021).
The Pharmacokinetics and Pharmacodynamics of Buprenorphine in Neonatal Abstinence Syndrome; Clinical Pharmacology & Therapeutics; (2018).
Buprenorphine for the Treatment of the Neonatal Abstinence Syndrome.; The New England journal of medicine; (2017).

�ֲ��ý